Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 6 of 6 descriptions
No. | 薬物名(臨床試験情報から抽出) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab (Ponvory (TN)) Interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolim ... | 12件: Acetate Acetate,Alemtuzumab, Cladribine, Dimethyl fumarate, Fingolimod, Glatiramer, Natalizumab, Ocrelizumab, Ofatumumab, Ponesimod (Ponvory), Rituximab, Teriflunomide 12件: Acetate, Alemtuzumab, Cladribine, Dimethyl fumarate, Fingolimod, Glatiramer, Natalizumab, Ocrelizumab, ... | 10件: Cladribine
Cladribine
,Alemtuzumab , Rituximab , Dimethyl fumarate , Ocrelizumab , Natalizumab , Ofatumumab , Fingolimod , Teriflunomide , Ponesimod (Ponvory (TN)) 💬 10件: Cladribine , Alemtuzumab , Rituximab , Dimethyl fumarate , Ocrelizumab , Natalizuma ... 1. Interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab
| 7件: CD52 CD52,DHODH, ITGA4, KEAP1, MS4A1, RRM1, S1PR1 💬 1. Interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab | 30件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Biosynthesis of cofactors, Cell adhesion molecules, Chemical carcinogenesis - reactive oxygen species, Dilated cardiomyopathy, Drug metabolism - other enzymes, ECM-receptor interaction, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Glutathione metabolism, Hematopoietic cell lineage, Hepatocellular carcinoma, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, Metabolic pathways, Neuroactive ligand-receptor interaction, Nucleotide metabolism, PI3K-Akt signaling pathway, Parkinson disease, Pathways in cancer, Purine metabolism, Pyrimidine metabolism, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, Ubiquitin mediated proteolysis, Yersinia infection 💬 30件: Arrhythmogenic right ventricular cardiomyopathy, Biosynthesis of cofactors, Cell adhesion molec ... | 1件: 13 13 💬1. Interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab
| ||||||||||||||||||||||||||||
2 | PONESIMOD (Ponvory (TN)) | 1件: Ponesimod Ponesimod (Ponvory) | 1件: Ponesimod
Ponesimod
(Ponvory (TN)) 💬2. PONESIMOD
| 1件: S1PR1 S1PR1 💬2. PONESIMOD
| 3件: FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway ... | 1件: 13 13 💬2. PONESIMOD
| ||||||||||||||||||||||||||||
3 | Ponesimod 10 mg (Ponvory (TN)) | 1件: Ponesimod Ponesimod (Ponvory) | 1件: Ponesimod
Ponesimod
(Ponvory (TN)) 💬3. Ponesimod 10 mg
| 1件: S1PR1 S1PR1 💬3. Ponesimod 10 mg
| 3件: FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway ... | 1件: 13 13 💬3. Ponesimod 10 mg
| ||||||||||||||||||||||||||||
4 | Ponesimod 20 mg (Ponvory (TN)) | 1件: Ponesimod Ponesimod (Ponvory) | 1件: Ponesimod
Ponesimod
(Ponvory (TN)) 💬4. Ponesimod 20 mg
| 1件: S1PR1 S1PR1 💬4. Ponesimod 20 mg
| 3件: FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway ... | 1件: 13 13 💬4. Ponesimod 20 mg
| ||||||||||||||||||||||||||||
5 | Ponesimod 40 mg (Ponvory (TN)) | 1件: Ponesimod Ponesimod (Ponvory) | 1件: Ponesimod
Ponesimod
(Ponvory (TN)) 💬5. Ponesimod 40 mg
| 1件: S1PR1 S1PR1 💬5. Ponesimod 40 mg
| 3件: FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway ... | 1件: 13 13 💬5. Ponesimod 40 mg
| ||||||||||||||||||||||||||||
6 | Ponvory | 1件: Ponesimod Ponesimod (Ponvory) | 1件: Ponesimod
Ponesimod
(Ponvory (TN)) 💬6. Ponvory
| 1件: S1PR1 S1PR1 💬6. Ponvory
| 3件: FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway ... | 1件: 13 13 💬6. Ponvory
|